Victor Ermilo Arana Argaez

Dr. Victor Ermilo Arana Argaez

Laboratorio de Farmacología, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Angel Josabad Alonso-CastroAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
EOElizabeth Ortiz-Sánchez
Elizabeth Ortiz-Sánchez
FDFabiola Domínguez
Fabiola Domínguez
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez
MJMaria del Carmen Juárez-Vázquez
Maria del Carmen Juárez-Vázquez
AGAlejandro García-Carrancá
Alejandro García-Carrancá

1 September 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RORolffy Ortiz-Andrade
Rolffy Ortiz-Andrade
ACAngel Cabañas-Wuan
Angel Cabañas-Wuan
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez
AAAngel Josabad Alonso-Castro
Angel Josabad Alonso-Castro
RZRocio Zapata-Bustos
Rocio Zapata-Bustos
AGAlejandro García-Carrancá
Alejandro García-Carrancá

23 May 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
AMAbril Bernardette Martínez-Rizo
Abril Bernardette Martínez-Rizo
RFRicardo Fosado-Rodríguez
Ricardo Fosado-Rodríguez
JTJulio César Torres-Romero
Julio César Torres-Romero
JLJulio César Lara-Riegos
Julio César Lara-Riegos
MRMario Alberto Ramírez-Camacho
Mario Alberto Ramírez-Camacho
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez

1 August 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
VFVilla-De la Torre Fabiola
Villa-De la Torre Fabiola
RKRalf Kinscherf
Ralf Kinscherf
GBGabriel Bonaterra
Gabriel Bonaterra
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez
MMMéndez-González Martha
Méndez-González Martha
RBRocio Borges-Argaez
Rocio Borges-Argaez

24 October 2017 in Food and Agricultural Immunology
Verified
Journal Article
Open access
ICIvan Chan-Zapata
Ivan Chan-Zapata
JCJaqueline Canul-Canche
Jaqueline Canul-Canche
KFKarla Fernández-Martín
Karla Fernández-Martín
ZMZhelmy Martín-Quintal
Zhelmy Martín-Quintal
JTJulio Cesar Torres-Romero
Julio Cesar Torres-Romero
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez
The present study aimed to examine the immunomodulatory properties of the methanolic (MeOH) extract from Pouteria. campechiana leaves in peritoneal macrophages of Balb/c mice. Peritoneal macrophages isolated from mice and Vero cells were treated with the MeOH extract from leaves. Cell viability of the macrophages and Vero cells were evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide method. The phagocytic activity, as nitric oxide (NO), hydrogen peroxide (H2O2), interleukin 6 (IL-6) and tumour necrosis factor α (TNF-α) production were evaluated on peritoneal macrophages. Results showed that the MeOH extract from leaves was able to stimulate the phagocytic activity and increase NO, H2O2 and cytokines production. The viability assays do not show cytotoxic effect on cell viability and cause a significative proliferative effect in the macrophages of a concentration-dependent manner. These results conclude that the MeOH extract from P. campechiana leaves possessed a stronger immunostimulatory effect in a concentration-dependent manner without affect the cell viability.

1 October 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Victor Ermilo Arana ArgaezVictor Ermilo Arana Argaez
Victor Ermilo Arana Argaez
VDVidal Delgado-Rizo
Vidal Delgado-Rizo
OPOSCAR ENRIQUE PIZANO PIZANO-MARTINEZ
OSCAR ENRIQUE PIZANO PIZANO-MARTINEZ
EMErika Aurora Martínez-García
Erika Aurora Martínez-García
BMBeatriz Teresita Martin Marquez
Beatriz Teresita Martin Marquez
MMMónica Vázquez-Del Mercado
Mónica Vázquez-Del Mercado
Phosphorylation is the most important post-translational event at a cellular level that is regulated by protein kinases. MAPK is a key player in the important cellular signaling pathway. It has been hypothesized that phosphorylation might have a role in the induction of break tolerance against some autoantigens such as SRP72. The aim of this study was to explore the pathways of phosphorylation and overexpression of the SRP72 polypeptide, using an in vitro model of Jurkat cells stimulated by recombinant human (rh)IL-1β in the presence of MAPK inhibitors. We used Jurkat cells as a substrate stimulated with rhIL-1β in the presence of MAPK inhibitors at different concentrations in a time course in vitro experiment by immunoprecipitation, immunoprecipitation-Western blotting, and real time PCR. Our results showed that rhIL-1β causes up-regulation of protein expression and phosphorylation of SRP72 in Jurkat cells. Inhibitors of the MAPK pathway ERK1/2 or p38α/β down-regulate the expression of SRP72 autoantigen in Jurkat cells stimulated by rhIL-1β. Our results highlight the importance of studying the pathways of activation and overexpression of autoantigens. It will be necessary to perform careful research on various kinases pathways, including MAPK in dermatomyositis and other rheumatic diseases, to help to explain the routes of activation and inhibition of autoantigens. The understanding of this process may help to develop new therapies to prevent and control the loss of tolerance toward own normal proteins.